HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Stock analysts at Northland Capmk lifted their FY2026 earnings per share estimates for HIVE Blockchain Technologies in a research note issued to investors on Tuesday, December 10th. Northland Capmk analyst M. Grondahl now expects that the company will earn $0.16 per share for the year, up from their prior forecast of $0.15. Northland Capmk currently has a “Strong-Buy” rating on the stock.
Several other brokerages have also recently weighed in on HIV. Cantor Fitzgerald upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Tuesday, October 29th. HC Wainwright upgraded HIVE Blockchain Technologies from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 15th.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Further Reading
- Five stocks we like better than HIVE Blockchain Technologies
- What is a Special Dividend?
- Why MongoDB’s Drop Could Be Your Best Buy Opportunity for 2025
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 2 AI Stocks That Gap and Crapped for a Dip Buying Opportunity
- What is the S&P/TSX Index?
- 4 Stocks Planning to Return Capital With Hefty Buyback Programs
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
